Bullfrog AI (US:BFRG) — Company Overview, News & Financial Data
Bullfrog AI uses AI to optimize clinical trials, enhancing the speed and efficiency of drug development.
Bullfrog AI
Bullfrog AI (NASDAQ:BFRG) leverages advanced artificial intelligence technologies to revolutionize how clinical trials are approached, aiming to significantly improve the speed and efficiency of bringing new medical treatments to market. The company specializes in utilizing machine learning algorithms to analyze vast datasets, helping to predict outcomes and optimize patient selection for clinical studies. Bullfrog AI's projects focus on reducing the time and costs associated with drug development, while aiming to increase the success rate of clinical trials. Their objective is to harness the power of AI to make the drug development process more efficient, accurate, and accessible, ultimately leading to faster delivery of safe and effective therapies to those in need.
Snapshot
Operations
Products and/or services of Bullfrog AI
- Using AI to analyze patient data for better clinical trial outcomes
- Developing personalized medicine tools through deep learning
- Providing predictive analytics services for healthcare companies
- Enhancing drug discovery processes with AI algorithms
- Offering analytics software for biotech and pharmaceutical research
- Building AI models for early disease detection and diagnosis
Bullfrog AI executive team
- Mr. Vininder SinghFounder, Chairman & CEO
- Mr. Joshua Blacher CPA, M.B.A.Chief Financial Officer
- Mr. J. T. KoffenbergerChief Information Officer
- Mr. Antonio V. MontanoChief Marketing Officer & Growth Strategy Leader
- Dr. Cetin Savkli Ph.D.Chief AI Advisor & Member of Advisory Board
- Dr. David P. Recker FACP, FACR, M.D.Chief Medical Officer
- Dr. Praveen Kudithipudi M.B.A., M.D.Chief Business Development Officer